Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2016 Filed Mar 8, 2016 22:23 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 3,400 | $56.10 | $190,740.00 |
DisclosureSEC source: 0001179110-16-021298 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,838 Read SEC document |
| March 08, 2016 Filed Mar 8, 2016 22:23 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 19,900 | $56.09 | $1,116,191.00 |
DisclosureSEC source: 0001179110-16-021298 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,238 Read SEC document |
| March 01, 2016 Filed Mar 2, 2016 22:23 UTC |
RICHMOND TIMOTHY J.SVP, Human Resources
|
SaleCommon stock, $0.01 par value | 10,792 | $55.00 | $593,560.00 |
DisclosureSEC source: 0001179110-16-020680 · edgar.xml · nonDerivative · entry 3 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,198 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:18 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
Tax withholdingCommon stock, $0.01 par value | 39,930 | $56.00 | $2,236,080.00 |
DisclosureSEC source: 0001179110-16-020675 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,882 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:19 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
Tax withholdingCommon stock, $0.01 par value | 45,658 | $56.00 | $2,556,848.00 |
DisclosureSEC source: 0001179110-16-020677 · edgar.xml · nonDerivative · entry 1 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,370 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 17:20 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
Tax withholdingCommon stock, $0.01 par value | 89,311 | $56.00 | $5,001,416.00 |
DisclosureSEC source: 0001179110-16-020678 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,421 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:22 UTC |
HURWICH THOMAS A.VP, Controller
|
SaleCommon stock, $0.01 par value | 1,444 | $55.25 | $79,776.67 |
DisclosureSEC source: 0001179110-16-020679 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,204 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:22 UTC |
HURWICH THOMAS A.VP, Controller
|
Tax withholdingCommon stock, $0.01 par value | 4,812 | $56.00 | $269,472.00 |
DisclosureSEC source: 0001179110-16-020679 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,648 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:23 UTC |
RICHMOND TIMOTHY J.SVP, Human Resources
|
SaleCommon stock, $0.01 par value | 2,074 | $55.32 | $114,737.83 |
DisclosureSEC source: 0001179110-16-020680 · edgar.xml · nonDerivative · entry 2 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,990 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:23 UTC |
RICHMOND TIMOTHY J.SVP, Human Resources
|
Tax withholdingCommon stock, $0.01 par value | 27,890 | $56.00 | $1,561,840.00 |
DisclosureSEC source: 0001179110-16-020680 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,064 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:24 UTC |
Schumacher Laura JExecutive Vice President
|
Tax withholdingCommon stock, $0.01 par value | 54,178 | $56.00 | $3,033,968.00 |
DisclosureSEC source: 0001179110-16-020683 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,138 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:25 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
SaleCommon stock, $0.01 par value | 1,776 | $55.38 | $98,349.55 |
DisclosureSEC source: 0001179110-16-020684 · edgar.xml · nonDerivative · entry 2 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,579 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:25 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
Tax withholdingCommon stock, $0.01 par value | 13,608 | $56.00 | $762,048.00 |
DisclosureSEC source: 0001179110-16-020684 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,355 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:26 UTC |
SEVERINO MICHAELEVP, R&D and CSO
|
Tax withholdingCommon stock, $0.01 par value | 8,053 | $56.00 | $450,968.00 |
DisclosureSEC source: 0001179110-16-020685 · edgar.xml · nonDerivative · entry 1 SEVERINO MICHAEL · CIK 0001609447 · EVP, R&D and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,856 Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 22:05 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
GrantOption (right to buy) · Derivative | 79,870 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019777 · edgar.xml · derivative · entry 1 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,870 Underlying: Common stock · 79,870 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 26,624 on 02/18/2017, 26,623 on 02/18/2018, and 26,623 on 02/18/2019. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 22:06 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
GrantOption (right to buy) · Derivative | 95,400 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019778 · edgar.xml · derivative · entry 1 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,400 Underlying: Common stock · 95,400 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 31,800 on 02/18/2017, 31,800 on 02/18/2018, and 31,800 on 02/18/2019. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 17:06 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
GrantOption (right to buy) · Derivative | 255,170 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019779 · edgar.xml · derivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,170 Underlying: Common stock · 255,170 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 85,057 on 02/18/2017, 85,056 on 02/18/2018, and 85,057 on 02/18/2019. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 22:07 UTC |
Gosebruch Henry OChief Strategy Officer
|
GrantOption (right to buy) · Derivative | 83,960 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019780 · edgar.xml · derivative · entry 1 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,960 Underlying: Common stock · 83,960 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 27,987 on 02/18/2017, 27,986 on 02/18/2018, and 27,987 on 02/18/2019. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 22:08 UTC |
HURWICH THOMAS A.VP, Controller
|
GrantOption (right to buy) · Derivative | 15,110 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019782 · edgar.xml · derivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,110 Underlying: Common shares · 15,110 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 5,037 on 02/18/2017, 5,036 on 02/18/2018, and 5,037 on 02/18/2019. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 22:08 UTC |
RICHMOND TIMOTHY J.SVP, Human Resources
|
GrantOption (right to buy) · Derivative | 42,370 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019783 · edgar.xml · derivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,370 Underlying: Common stock · 42,370 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 14,124 on 02/18/2017, 14,123 on 02/18/2018, and 14,123 on 02/1/8/2019. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 22:09 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
GrantOption (right to buy) · Derivative | 42,370 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019785 · edgar.xml · derivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,370 Underlying: Common stock · 42,370 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 14,124 on 02/18/2017, 14,123 on 02/18/2018, and 14,123 on 02/18/2019. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 22:10 UTC |
Schumacher Laura JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 78,450 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019786 · edgar.xml · derivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,450 Underlying: Common stock · 78,450 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exerciseable in annual increments of 26,150 on 02/18/2017, 26,150 on 02/18/2018, and 26,150 on 02/18/2019. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 22:37 UTC |
SEVERINO MICHAELEVP, R&D and CSO
|
GrantOption (right to buy) · Derivative | 91,990 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019789 · edgar.xml · derivative · entry 1 SEVERINO MICHAEL · CIK 0001609447 · EVP, R&D and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,990 Underlying: Common stock · 91,990 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,664 on 02/18/2017, 30,663 on 02/18/2018, and 30,663 on 02/18/2019. Read SEC document |
| February 18, 2016 Filed Mar 2, 2016 22:26 UTC |
SEVERINO MICHAELEVP, R&D and CSO
|
GrantOption (right to buy) · Derivative | 91,990 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-020685 · edgar.xml · derivative · entry 2 SEVERINO MICHAEL · CIK 0001609447 · EVP, R&D and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,990 Underlying: Common stock · 91,990 shares Expires 2026-02-17 Read SEC document |
| February 05, 2016 Filed Feb 9, 2016 22:13 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
Exercise / conversionOption (right to buy) · Derivative | 3,400 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001179110-16-018825 · edgar.xml · derivative · entry 5 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 0 Underlying: Common stock · 3,400 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2016 Filed Feb 9, 2016 22:13 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
Tax withholdingCommon stock, $0.01 par value | 2,112 | $56.76 | $119,877.12 |
DisclosureSEC source: 0001179110-16-018825 · edgar.xml · nonDerivative · entry 4 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 3,031 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by her spouse. Read SEC document |
| February 05, 2016 Filed Feb 9, 2016 22:13 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
Exercise / conversionCommon stock, $0.01 par value | 3,400 | $22.94 | $77,998.38 |
DisclosureSEC source: 0001179110-16-018825 · edgar.xml · nonDerivative · entry 3 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by her spouse. Read SEC document |
| December 31, 2015 Filed Jan 5, 2016 22:12 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 132 | $59.24 Strike: $0.00 | $7,819.68 |
DisclosureSEC source: 0001179110-16-017098 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,549 Underlying: Common Stock · 132 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2015 Filed Jan 5, 2016 17:12 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 582 | $59.24 Strike: $0.00 | $34,477.68 |
DisclosureSEC source: 0001179110-16-017099 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,698 Underlying: Common stock · 582 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature. Read SEC document |
| December 31, 2015 Filed Jan 5, 2016 22:13 UTC |
RAPP EDWARD JDirector
|
GrantStock Equivalent Units · Derivative | 557 | $59.24 Strike: $0.00 | $32,996.68 |
DisclosureSEC source: 0001179110-16-017101 · edgar.xml · derivative · entry 1 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,853 Underlying: Common Stock · 557 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2015 Filed Jan 5, 2016 17:14 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 582 | $59.24 Strike: $0.00 | $34,477.68 |
DisclosureSEC source: 0001179110-16-017102 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,067 Underlying: Common Stock · 582 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 09, 2015 Filed Dec 11, 2015 22:22 UTC |
Gosebruch Henry OChief Strategy Officer
|
GrantCommon stock, $0.01 par value | 64,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016163 · edgar.xml · nonDerivative · entry 2 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,050 F2 · shares: A retention award of restricted stock granted under the AbbVie 2013 Incentive Stock Program. The award vests in annual increments of 21,514 on 12/09/2016, 21,513 on 12/09/2017, and 21,513 on 12/09/2018. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| December 09, 2015 Filed Dec 11, 2015 22:22 UTC |
Gosebruch Henry OChief Strategy Officer
|
GrantCommon stock, $0.01 par value | 26,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016163 · edgar.xml · nonDerivative · entry 1 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,510 F1 · shares: Performance vested restricted stock granted under the AbbVie 2013 Incentive Stock Program. The award has a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| December 07, 2015 Filed Dec 30, 2015 17:14 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
GiftCommon stock, $0.01 par value | 2,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016813 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,732 Read SEC document |
| November 04, 2015 Filed Dec 30, 2015 22:13 UTC |
Schumacher Laura JExecutive Vice President
|
GiftCommon stock, $0.01 par value | 800 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016810 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,316 Read SEC document |
| September 30, 2015 Filed Oct 2, 2015 20:47 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 144 | $54.41 Strike: $0.00 | $7,835.04 |
DisclosureSEC source: 0001179110-15-013703 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,378 Underlying: Common Stock · 144 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2015 Filed Oct 2, 2015 16:48 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 634 | $54.41 Strike: $0.00 | $34,495.94 |
DisclosureSEC source: 0001179110-15-013704 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,997 Underlying: Common stock · 634 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature. Read SEC document |
| September 30, 2015 Filed Oct 2, 2015 20:48 UTC |
RAPP EDWARD JDirector
|
GrantStock Equivalent Units · Derivative | 606 | $54.41 Strike: $0.00 | $32,972.46 |
DisclosureSEC source: 0001179110-15-013706 · edgar.xml · derivative · entry 1 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,234 Underlying: Common Stock · 606 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2015 Filed Oct 2, 2015 16:49 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 634 | $54.41 Strike: $0.00 | $34,495.94 |
DisclosureSEC source: 0001179110-15-013707 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,295 Underlying: Common Stock · 634 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 10, 2015 Filed Oct 2, 2015 16:50 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
GiftCommon stock, $0.01 par value | 1,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-013708 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,362 Read SEC document |
| August 28, 2015 Filed Oct 2, 2015 16:50 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
GiftCommon stock, $0.01 par value | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-013708 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 4,600 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| August 28, 2015 Filed Oct 2, 2015 16:50 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
GiftCommon stock, $0.01 par value | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-013708 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,837 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 65,000 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · derivative · entry 30 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,953 Underlying: Common stock · 65,000 shares Expires 2023-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 100 | $71.17 | $7,116.50 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 29 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513,208 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 800 | $71.16 | $56,928.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 28 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513,308 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 500 | $71.16 | $35,577.50 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 27 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,108 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 600 | $71.15 | $42,690.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 26 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,608 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 100 | $71.15 | $7,114.50 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 25 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,208 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 500 | $71.14 | $35,570.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 24 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,308 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 800 | $71.13 | $56,904.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 23 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,808 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.